CoolSculpting: Key Statistics, Clinical Research & Patient Data 2026

An Evidence-Based Overview of Cryolipolysis Efficacy, Safety & Patient Demographics

• 823% — Increase in CoolSculpting treatments in just 3 years following FDA approval in 2010
• 20–25% — Fat reduction per session achieved at targeted body areas, per multiple clinical studies
• 46.6% — Average abdominal fat reduction measured six months after a single CoolSculpting treatment in a 2021 study
• 77% — Of participants in a 2016 study reported visible fat reduction after CoolSculpting treatment
• 0.0051% — Original reported PAH incidence — one of CoolSculpting’s rarest but most publicized complications
• 83% — Patient satisfaction rate for CoolSculpting of the submental area (double chin), per clinic data
• 86.83% — Of patients in the PAH systematic review were female, reflecting CoolSculpting’s gender demographics
• 75% — Reduction in PAH incidence achieved with newer CoolSculpting device models, per Canadian multicenter study
• 14.67–28.5% — Fat reduction range measured by caliper across 19 studies in the Plastic and Reconstructive Surgery systematic review

SECTION 2 — Statistical Deep Dives

823% Treatment Growth in 3 Years — CoolSculpting’s Historic Adoption Trajectory

CoolSculpting treatments increased by 823% in just three years following the procedure’s FDA approval in 2010, according to a 2013 study cited by Healthline — one of the most dramatic adoption curves of any non-invasive cosmetic procedure in the history of aesthetic medicine. This explosive early growth reflected a convergence of unmet demand (patients seeking non-surgical fat reduction without the recovery and risks of liposuction), celebrity and media visibility, and an aggressive national rollout of CoolSculpting devices into dermatology practices and medical spas. The procedure received FDA clearance specifically for the reduction of visible fat bulges on the abdomen, flanks, thighs, upper arms, back, buttocks, and under the chin — covering a broad anatomical range that opened the treatment to a wide patient population. Non-surgical fat reduction, including cryolipolysis, is ranked as the fourth most frequent non-invasive procedure by the Aesthetic Society — behind botulinum toxin, fillers, and laser treatments. The historical growth data and current FDA-approved indications are summarized at healthline.com.

20–25% Fat Reduction Per Session — The Core Clinical Efficacy Benchmark

Clinical studies consistently demonstrate that CoolSculpting can achieve a 20–25% reduction in fat at the targeted treatment area per session, making it the most widely cited efficacy benchmark for cryolipolysis in both clinical literature and patient communications. This reduction reflects the procedure’s mechanism of selective cryoapoptosis: fat cells (adipocytes), unlike the surrounding skin and muscle tissue, are uniquely vulnerable to crystallization at cold temperatures between -9°C and -11°C, causing controlled cell death that is then processed and eliminated by the body’s lymphatic system over two to four months post-treatment. A JAAD review confirmed that CoolSculpting can achieve fat reduction of up to 25% in the treated area, and further noted that the procedure is generally safe and well-tolerated with few reported complications. Patients should understand this benchmark applies to the specific fat layer in the treatment zone, not overall body weight, and that individual results vary based on treatment area, applicator used, and number of sessions completed. The JAAD clinical review data are at jaad.org.

46.6% Abdominal Fat Reduction at 6 Months — 2021 Clinical Study Results

A 2021 clinical study evaluating the effects of a single CoolSculpting treatment on 30 female participants found that six months after treatment, the average reduction in abdominal fat was 46.6% — a figure substantially higher than the standard 20–25% per-session benchmark, reflecting the cumulative fat elimination process that continues for up to six months post-treatment as the body metabolizes crystallized adipocytes. The same study also found evidence of tightened skin in the treatment area, a secondary benefit that researchers noted warrants further investigation as a potential additional indication for cryolipolysis. A 2020 study separately found that cryolipolysis using newer, better-fitting applicators is safe and effective in quickly reducing excess fat across various body areas, and a 2020 review confirmed that patients with cold-induced conditions such as Raynaud’s disease should not undergo the procedure. Body contours continue to improve for up to six months as fat cells are eliminated. The 2021 study and related research are summarized at medicalnewstoday.com.

77% of Participants Report Visible Fat Reduction — Patient-Reported Efficacy Data

A 2016 clinical study of CoolSculpting found that 77% of participants reported visible fat reduction following their treatment, according to data reported by Healthline and Slim Studio Atlanta. Patient-reported satisfaction data for CoolSculpting varies by treatment area: satisfaction rates for submental fat (double chin) treatment run approximately 83%, while satisfaction across all body areas averages in the high 70s to mid-80s depending on the study population and provider quality. CoolSculpting Elite, the next-generation system introduced with dual-applicator capability and redesigned contoured applicators, has shown improved body coverage and efficiency per treatment session compared to classic CoolSculpting — and modern results data may reflect higher satisfaction rates than earlier studies conducted on the original device. Patient selection remains the primary driver of satisfaction outcomes: patients near their ideal weight with isolated, pinchable fat pockets consistently show superior results to those who are significantly overweight, for whom the procedure may produce less noticeable absolute improvement. The satisfaction rate data and patient profile analysis are at slimstudioatlanta.com.

0.0051% Original PAH Incidence — The Rare Complication That Changed the Conversation

Paradoxical adipose hyperplasia (PAH) — a rare complication in which cryolipolysis paradoxically stimulates fat growth rather than fat elimination in the treated area — was first reported in a PMC paper estimating its incidence at 0.0051% (approximately one in 20,000 cycles). However, subsequent multicenter real-world data has revised this estimate upward significantly: a Canadian multicenter study of 8,658 cycles in 2,114 patients found PAH incidence rates of 0.05% to 0.39% — substantially higher than the manufacturer’s quoted rate of 0.025%. StatPearls further notes that some estimates suggest PAH may occur in up to 2% of treatments or 1 in 50 cases in higher-risk patient populations. PAH appears more commonly in male patients, after abdominal treatment, and with older CoolSculpting applicators. Newer CoolSculpting device models reduced PAH incidence by over 75% in the Canadian study. The original PMC PAH case report establishing the 0.0051% incidence is at pmc.ncbi.nlm.nih.gov.

83% Submental Satisfaction Rate — Under-Chin CoolSculpting Leads in Patient Approval

CoolSculpting for submental fullness (the ‘double chin’) carries an ample satisfaction rate of approximately 83%, according to clinical data from Slim Studio Atlanta, making it one of the highest-satisfaction treatment areas for the procedure. This strong satisfaction rate reflects the procedure’s particular effectiveness at the submental location, where the fat pad is well-defined and the applicator can be precisely positioned to target the isolated fat deposit beneath the chin without affecting adjacent structures. The CoolMini applicator, designed specifically for smaller areas including the chin, jawline, and inner thighs, has been a driver of this satisfaction trend by enabling more precise cryolipolysis in anatomical areas where earlier, larger applicators were less effective. Non-surgical fat reduction procedures as a category — including CoolSculpting, SculpSure, Emsculpt Neo, and Vanquish — are ranked among the top non-surgical contouring options by clinical effectiveness with less recovery time than surgical alternatives, according to body contouring procedure data from drmmacdonald.com.

86.83% Female Patients — The Gender Demographics of CoolSculpting in Systematic Review Data

A systematic review and meta-analysis of PAH incidence after cryolipolysis, published in Aesthetic Surgery Journal Open Forum in January 2025, reported that females comprised 86.83% of the study population, with males at 13.17% — a gender split consistent with the broader aesthetic procedure market but notable given that PAH appears more commonly in male patients despite their lower overall utilization of the procedure. This demographic data reflects the overall CoolSculpting patient base: the procedure is predominantly sought by women aged 30–60 who are near their goal weight and targeting specific problem areas including the abdomen, flanks, and thighs. Newer CoolSculpting models reduced PAH incidence by 75% in the Canadian multicenter study, and the review confirmed that this trend toward improved safety profiles with updated devices aligns with multiple independent research groups. Male interest in body contouring is growing — with the non-surgical body contouring market actively expanding its male demographic through targeted marketing and social media outreach. The 2025 systematic review data are at academic.oup.com.

75% PAH Reduction with Newer Devices — Technology Advancement Dramatically Improves CoolSculpting Safety

The Canadian multicenter study of 8,658 CoolSculpting cycles in 2,114 patients found that the implementation of newer CoolSculpting device models dramatically reduced PAH incidence by over 75% at all participating centers, providing the most compelling real-world evidence that applicator engineering improvements have meaningfully addressed the procedure’s most serious complication. This device-generation safety improvement is clinically significant: it means the PAH incidence literature from before 2018 may overstate current risk, and patients treated with current-generation CoolSculpting Elite equipment are at materially lower risk than those who received treatment in the early years of the procedure. Despite this progress, StatPearls notes ethical concerns about CoolSculpting being performed in medspas by individuals with limited medical training, raising patient safety, informed consent, and complication management concerns when the procedure is delivered outside physician-supervised settings. Patients are advised to seek CoolSculpting treatment from providers with medical credentials and physician oversight. The multicenter PAH incidence study is at pmc.ncbi.nlm.nih.gov.

14.67–28.5% Fat Reduction Across 19 Studies — The Plastic and Reconstructive Surgery Systematic Review

A systematic review of cryolipolysis clinical data published in Plastic and Reconstructive Surgery, one of the field’s leading peer-reviewed journals, analyzed 19 eligible studies and found that average fat reduction measured by caliper ranged from 14.67% to 28.5% across the study population, while ultrasound-measured reduction ranged from 10.3% to 25.5% — reflecting the breadth of outcomes across different patient populations, treatment areas, and applicator generations. Critically, the review found no significant impact on lipid levels or liver function tests after cryolipolysis treatments in any study, confirming that the fat cells eliminated by cryolipolysis are safely metabolized and do not adversely affect systemic metabolism or organ function. Only mild, short-term side effects — erythema, swelling, and pain — were noted across the included studies. The review concluded that cryolipolysis is a promising procedure for non-surgical fat reduction, representing a compelling alternative to liposuction and more invasive methods with a limited side effect profile and significant fat reduction capability. The full systematic review is at journals.lww.com.

Frequently Asked Questions

How much does CoolSculpting cost?

CoolSculpting pricing in the United States is quoted per treatment cycle (applicator placement), with the total cost depending on the number of areas treated, the number of cycles per area, the type of applicator used, and the geographic market. General national benchmarks: a single treatment cycle on one area typically costs $600–$1,000; a standard treatment session covering one full area (such as the abdomen or both flanks) commonly costs $1,500–$3,000; and a full multi-area treatment plan addressing the abdomen, flanks, and thighs might run $4,000–$8,000 or more in total. The American Society of Plastic Surgeons has historically cited an average CoolSculpting session cost of approximately $2,000–$4,000 for typical multi-area patients. CoolSculpting Elite, the current-generation dual-applicator system, may be priced differently from the original CoolSculpting device — confirm with the provider. Most cosmetic CoolSculpting is not covered by health insurance. Many practices offer package pricing for multiple sessions or treatment areas at a discounted rate. Financing through third-party medical credit providers (CareCredit, Alpheon Credit) is widely available.

How much is CoolSculpting equipment?

The cost of purchasing professional CoolSculpting equipment for a clinical practice varies depending on the device generation, the number of applicators included, and whether the purchase is new or refurbished. New CoolSculpting Elite systems — the current generation dual-applicator platform from AbbVie/Allergan Aesthetics — typically range from approximately $75,000 to $150,000+ per unit when purchased new, including the base unit, a standard set of applicators, and initial training. Applicators are sold separately and add significant additional cost, with popular applicators priced in the range of $10,000–$20,000 each depending on type. Many practices lease CoolSculpting equipment through Allergan’s financing programs rather than purchasing outright, with monthly lease payments often structured around a minimum cycle commitment. Refurbished or used CoolSculpting systems are available through third-party medical equipment resellers at lower prices, though warranty coverage and applicator compatibility should be carefully verified. Service contracts for ongoing maintenance and calibration are an important ongoing cost consideration for any CoolSculpting investment.

How effective is CoolSculpting?

CoolSculpting is clinically effective for non-surgical fat reduction in appropriately selected patients. The evidence base includes: a 20–25% per-session fat reduction benchmark confirmed across multiple peer-reviewed clinical studies; a 46.6% average abdominal fat reduction measured at six-month follow-up in a 2021 controlled study of 30 female patients; fat reduction by caliper ranging from 14.67% to 28.5% across 19 studies reviewed in Plastic and Reconstructive Surgery; patient satisfaction rates of approximately 77–83% depending on treatment area; and FDA clearance for nine body areas including the abdomen, flanks, thighs, upper arms, back, buttocks, under chin, and jawline. CoolSculpting is most effective for patients who are near their target weight, have specific, isolated fat deposits that are pinchable with the applicator, and have realistic expectations about contour improvement rather than significant weight loss. It is less effective for patients with significant overall obesity, diffuse fat distribution, or skin laxity that will not improve with fat reduction. Results continue to develop for up to four to six months post-treatment as the body eliminates crystallized fat cells through the lymphatic system.

Does CoolSculpting really work?

Yes — CoolSculpting works for its intended indication: non-surgical reduction of localized, subcutaneous fat in patients near their goal weight. The science is well-established: cryolipolysis exploits the fact that fat cells (adipocytes) are uniquely sensitive to cold temperatures and undergo programmed cell death (apoptosis) at around -9°C to -11°C, while the overlying skin and surrounding tissue remain unharmed. The FDA cleared the device in 2010 based on controlled clinical trial data, and over a decade of post-market use has confirmed its efficacy in real-world settings. A 2018 systematic review published in Plastic and Reconstructive Surgery concluded that cryolipolysis is ‘safe and effective in reducing the fat layer and improving body contouring.’ Treatments increased by 823% in just three years after FDA approval, and non-surgical fat reduction (including cryolipolysis) is now the fourth most frequently performed non-invasive aesthetic procedure category. However, CoolSculpting does not work as a weight loss tool — the number on the scale does not typically change significantly after treatment. It works specifically as a body contouring procedure that reshapes proportions by reducing targeted fat deposits, not overall body mass.

How does CoolSculpting work?

CoolSculpting uses a patented process called cryolipolysis — the controlled application of sustained cold temperatures to freeze subcutaneous fat cells without damaging the overlying skin. The mechanism relies on the biological principle of selective photothermolysis’s cold-temperature equivalent: fat cells crystallize and undergo apoptosis at temperatures that skin, nerves, and muscle tissue tolerate without injury. The treatment process: (1) A gel pad is placed on the skin to protect the surface. (2) A vacuum-powered applicator is placed over the target fat bulge, drawing the tissue between two cooling panels using suction. (3) The panels cool the fat tissue to approximately -9°C to -11°C for 35–60 minutes per cycle, depending on the applicator type. (4) The cold exposure triggers adipocyte crystallization and initiates programmed cell death. (5) Over the following two to four months, the body’s immune system (phagocytes) identifies and eliminates the damaged fat cells through the lymphatic system, gradually reducing the fat layer in the treated area. The elimination process is why results are not immediately visible and why improvement continues for up to six months post-treatment. No incisions, anesthesia, or needles are involved, and most patients can resume normal activities the same day.

What is CoolSculpting?

CoolSculpting is the brand name for a non-invasive body contouring procedure using cryolipolysis technology, developed by ZELTIQ Aesthetics (now owned by Allergan Aesthetics, an AbbVie company) and FDA-cleared in 2010. It is the most well-known brand of cryolipolysis — a technique that uses controlled cooling to freeze and permanently eliminate targeted pockets of subcutaneous (under-skin) fat without surgery. CoolSculpting is not a weight loss treatment; it is a body-shaping procedure for patients near their ideal weight who want to reduce specific, stubborn fat deposits that do not respond adequately to diet and exercise. FDA-cleared treatment areas include: abdomen, flanks (love handles), inner and outer thighs, upper arms, back fat (bra fat), underneath the chin (submental), the jawline, and the buttocks (for banana roll reduction). The current-generation device, CoolSculpting Elite, features two simultaneous applicators with redesigned cup shapes that better conform to body contours for improved coverage and efficiency. Because the eliminated fat cells do not regenerate, results are considered permanent for the treated fat deposits, provided weight remains stable.

How many times do you have to do CoolSculpting?

The number of CoolSculpting sessions required varies by patient anatomy, the number of areas being treated, the volume of fat in each area, and the degree of improvement desired. General guidelines: a single treatment cycle reduces fat in the target area by 20–25%, which is often visible and satisfying for patients with smaller, well-defined fat deposits. Two sessions spaced four to eight weeks apart are commonly recommended for areas with more significant fat volume or for patients who want more dramatic improvement in a single area. For patients treating multiple areas — such as the abdomen, flanks, and inner thighs simultaneously — CoolSculpting Elite’s dual-applicator design reduces the number of separate visits needed by treating two areas simultaneously. Most providers recommend at least two initial sessions per area to achieve optimal results and then reassess. Since CoolSculpting permanently eliminates treated fat cells, most patients do not need ongoing treatments in the same area if weight remains stable. Additional sessions may be warranted years later if natural aging or weight fluctuations cause new fat accumulation.

Is CoolSculpting permanent?

CoolSculpting produces permanent elimination of the specific fat cells it destroys — those adipocytes, once crystallized and cleared by the body’s immune system, do not regenerate. In this sense, the fat reduction achieved by CoolSculpting in the treated area is permanent. However, this permanence is conditional on the patient maintaining a stable weight: the remaining fat cells throughout the body — including in the treated area — are capable of enlarging if significant weight is gained after treatment, which can partially or fully reverse the contour improvement achieved. Additionally, aging-related changes in skin elasticity and fat redistribution can alter body contours over time, independent of fat cell count. The paradoxical adipose hyperplasia (PAH) complication, which causes fat growth rather than loss in the treated area in a small percentage of patients, is the one situation in which CoolSculpting can produce a permanent adverse change rather than improvement — underscoring the importance of choosing experienced, medically supervised providers and understanding the procedure’s risk profile before treatment.

Is CoolSculpting expensive?

CoolSculpting is considered a mid-to-high-cost aesthetic procedure by most standards. At $600–$1,000 per treatment cycle and typically two or more cycles needed per area, a single-area treatment commonly runs $1,500–$3,000. Multi-area treatment plans covering three to five body areas can easily reach $5,000–$12,000 in total. By comparison, surgical liposuction for the same areas typically costs $3,000–$10,000 — meaning CoolSculpting is not dramatically cheaper than surgery for patients treating multiple large areas, though it avoids the recovery, anesthesia, and surgical risks. Whether CoolSculpting is ‘expensive’ depends on the patient’s perspective: for someone treating one small, well-defined area (such as submental fat or inner knees), the cost may be reasonable and comparable to other aesthetic treatments. For someone hoping to contour a large number of areas, the cumulative cost may approach or exceed surgical alternatives. Many practices offer financing, package discounts, and promotional pricing during specific periods. Comparing total-course cost — including all sessions needed — rather than per-session price is the most accurate way to budget for CoolSculpting.

Sources

1. healthline.com — CoolSculpting: Does It Work? | Healthline (823% growth data; FDA approval history)

2. jaad.org — Paradoxical Adipose Hyperplasia in CoolSculpting: A Review | JAAD (20–25% fat reduction; PAH data)

3. medicalnewstoday.com — CoolSculpting: Does It Work and Is It Safe? | Medical News Today (46.6% abdominal reduction)

4. slimstudioatlanta.com — What Is the Success Rate of CoolSculpting? | Slim Studio Atlanta (77% visible reduction; 83% submental satisfaction)

5. pmc.ncbi.nlm.nih.gov — Paradoxical Adipose Hyperplasia After Cryolipolysis (PMC — 0.0051% incidence paper)

6. drmmacdonald.com — Body Contouring Statistics: Non-Surgical Procedures Leading the Market | Dr. MacDonald

7. academic.oup.com — Incidence of PAH After Cryolipolysis: Systematic Review & Meta-Analysis | Aesthetic Surgery Journal (2025)

8. pmc.ncbi.nlm.nih.gov — Multicenter Evaluation of PAH Following Cryolipolysis: 8,658 Cycles (PMC — 75% PAH reduction with newer devices)

9. journals.lww.com — Cryolipolysis for Fat Reduction and Body Contouring: Safety and Efficacy | Plastic and Reconstructive Surgery